Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE
HIGHLIGHTS • Pegcetacoplan demonstrated increasing efficacy over time through 36 months. • Pegcetacoplan is the first GA treatment to show benefit in prespecified functional analyses. • Safety outcomes in the…